There are 2789 resources available
436P - Phase (Ph) II study of taminadenant (NIR178) + spartalizumab (PDR001) in patients (pts) with microsatellite stable (MSS) colorectal cancer (CRC)
Presenter: Omar Saavedra Santa Gadea
Session: ePoster Display
437P - Quality of life (QoL) in patients (pts) with microsatellite instability (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer (mCRC) treated with nivolumab (NIVO) alone or in combination with ipilimumab (IPI): CheckMate 142
Presenter: Eric Van Cutsem
Session: ePoster Display
438P - First line treatment patterns in BRAFV600E-mutant metastatic colorectal cancer patients (mCRC): The CAPSTAN European retrospective study
Presenter: Bernard Asselain
Session: ePoster Display
439P - Characteristics and treatment patterns among patients with HER2-amplified advanced/metastatic colorectal cancer (mCRC): A clinical-genomic database study
Presenter: John Strickler
Session: ePoster Display
440P - Response to BRAF inhibitors combined with anti-EGFR after previous anti-EGFR exposure for BRAF V600E mutant metastatic colorectal cancer patients
Presenter: Emilie Hafliger
Session: ePoster Display
321P - Breast cancer in women younger than 40 years: Increasing proportion of new cases and deaths in Brazil
Presenter: Renata Bonadio
Session: ePoster Display
322P - Intrathecal catheter for chemotherapy in leptomeningeal metastatic breast cancer
Presenter: Lila Autier
Session: ePoster Display
323P - Clinical profile and prognosis of metastatic breast cancer with pseudocirrhosis: A rare and dismal condition
Presenter: Maria Fernanda Simões
Session: ePoster Display
325P - Trends of primary tumor resection in de novo metastatic breast cancer: The experience of a Mexican center
Presenter: Fabio Gonzalez-Mondellini
Session: ePoster Display